(Q36916140)

17 August 2017

Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers (English)

1 reference

17 August 2017

1 reference

1 reference

Siranoush Manoukian

11

0 references

Jan Lubiński

2

object named as

Jan Lubinski

1 reference

17 August 2017

8

Susan L Neuhausen

1 reference

17 August 2017

19

Steven A Narod

1 reference

17 August 2017

12

Gad Rennert

1 reference

17 August 2017

14

Claudine Isaacs

1 reference

17 August 2017

3

Jacek Gronwald

1 reference

17 August 2017

17

Mary Daly

1 reference

17 August 2017

10

Parviz Ghadirian

1 reference

17 August 2017

7

Charmaine Kim-Sing

1 reference

17 August 2017

1

Andrea Eisen

1 reference

Hereditary Breast Cancer Clinical Study Group

17 August 2017

20

object named as

Hereditary Breast Cancer Clinical Study Group

1 reference

17 August 2017

4

Pal Moller

1 reference

17 August 2017

6

Jan Klijn

1 reference

17 August 2017

Henry T Lynch

5

1 reference

17 August 2017

Lucy Gilbert

9

1 reference

17 August 2017

Eitan Friedman

13

1 reference

17 August 2017

Eliot Rosen

15

1 reference

17 August 2017

Barry Rosen

16

1 reference

17 August 2017

Ping Sun

18

1 reference

17 August 2017

language of work or name

English

0 references

publication date

23 September 2008

1 reference

Journal of the National Cancer Institute

17 August 2017

1 reference

17 August 2017

100

1 reference

17 August 2017

19

1 reference

17 August 2017

1361-1367

1 reference

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Ovarian cancer and hormone replacement therapy in the Million Women Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

The decrease in breast-cancer incidence in 2003 in the United States

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Endometrial cancer and hormone-replacement therapy in the Million Women Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Breast cancer and hormone-replacement therapy in the Million Women Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2556701

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FJNCI%2FDJN313

Frequency of breast cancer attributable to BRCA1 in a population-based series of American women

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18812548

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JNCI/DJN313

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

18812548

1 reference